Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT07472660

Intensive Prevention Program After Decompensated Heart Failure

Led by Herzzentrum Bremen · Updated on 2026-03-16

200

Participants Needed

1

Research Sites

178 weeks

Total Duration

On this page

Sponsors

H

Herzzentrum Bremen

Lead Sponsor

N

Nationale Herzallianz (NHA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Introduction: Care for patients with heart failure (HF) often remains inadequate, even though a variety of treatment options exist. Guideline-based, multimodal therapy is rarely fully established, partly due to insufficient intersectoral cooperation and insufficient patient training. Heart failure nurses (HFN) as specialized non-medical personnel are intended to contribute to better patient care. E-learning and the use of mobile devices are modern options for training patients. However, previous studies in this regard only examined a few aspects of therapy and came to different results. The Intensive Prevention Program after decompensated Heart Failure (IPP-HF) will investigate if a one-year web-based and HFN-guided program for patients hospitalized due to congestive heart failure leads to a lower rate of re-hospitalization and an improvement in quality of life (QoL). Study design: Patients hospitalized for decompensated HF will be prospectively enrolled and assigned to either a 12 months HFN-guided intensive prevention program or standard care. The prevention program will include patient training per e-learning, use of an app for HF, linking the patient to an interdisciplinary heart failure network and referral to heart sports groups or other specialists and will include regular monitoring for signs of (threatening) decompensation, medication, fitness and QoL. The combined primary study endpoint will comprise rehospitalization for decompensated HF and QoL after 1 year. Secondary endpoints will include mortality, completeness of anticongestive medication, changes in ejection fraction, NTproBNP, ferritin, transferrin, 6-minute walking distance, relative maximum oxygen-consumption (peak VO2), NYHA-class, depression status (PHQ-9) and knowledge about HF (AHFKT). Conclusions :The randomized IPP-HF study will evaluate the effect of an web-based and HFN-guided prevention program on rehospitalization and QoL for patients hospitalized for decompensated heart failure.

CONDITIONS

Official Title

Intensive Prevention Program After Decompensated Heart Failure

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Hospitalization due to symptomatic heart failure (NYHA II-IV) with signs of congestion, ejection fraction 60;40%, and elevated NTproBNP
  • Age between 18 and 80 years
  • Life expectancy greater than 2 years
  • Access to internet, physical and mental ability, and consent to participate in a web-based prevention program guided by heart failure nurses
Not Eligible

You will not qualify if you...

  • Persistent NYHA IV at discharge
  • Reversible cause of heart failure (e.g., tachycardiomyopathy, acute myocarditis, pacemaker-induced heart failure)
  • Ejection fraction greater than 40% (HFmrEF, HFpEF)
  • Refusal or inability to give informed consent
  • Participation in another clinical trial
  • Exercise limitations due to non-heart failure conditions (e.g., disabling orthopedic, rheumatological, hematooncological, neurological diseases, severe lung diseases)
  • Major non-cardiac conditions adversely affecting survival (e.g., malignant comorbidities or end-stage liver cirrhosis with prognosis less than 2 years)
  • Inability to cooperate with the study protocol (e.g., chronic active drug/alcohol abuse, severe mental disorders, deafness or severe language barrier without translation, inability to attend study visits)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Bremen Institute for Heart- and Circulation Research

Bremen, Germany, 28277

Actively Recruiting

Loading map...

Research Team

S

Stephan Ruehle

CONTACT

H

Harm Wienbergen

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here